Lecture list
2017
Feb - Genotoxicity in the pharmaceutical industry. University of Leiden, Leiden, POT course Mutagenicity...
2008
Jan - High throughput screening for in vitro toxicity testing: A gradual acceptance of new test methods. 3rd
meeting ...
Upcoming SlideShare
Loading in …5
×

Lecture list

308 views

Published on

Published in: Career
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
308
On SlideShare
0
From Embeds
0
Number of Embeds
14
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Lecture list

  1. 1. Lecture list 2017 Feb - Genotoxicity in the pharmaceutical industry. University of Leiden, Leiden, POT course Mutagenicity and carcinogenicity, 17 February, 2017 2016 Dec - Reproductive hormones and menopause. University College of Middelburg, Middelburg, Guest speaker Bachelor physiology program. 9 December, 2016 May - Reproductive hormones and menopause. University College of Middelburg, Middelburg, Guest speaker Bachelor physiology program. 9 May, 2016 2015 Dec - Reproductive hormones and menopause. University College of Middelburg, Middelburg, Guest speaker Bachelor physiology program. 15 December, 2015 2014 Dec - Reproductive hormones and menopause. University College of Middelburg, Middelburg, Guest speaker Bachelor physiology program. 9 December, 2014 2013 Feb - Genotoxicity in the pharmaceutical industry. University of Leiden, Leiden, POT course Mutagenicity and carcinogenicity, 8 February, 2013 Mar - Toxicogenomics in the pharmaceutical industry. University of Maastricht, Maastricht, POT course Toxicogenomics, 1 March, 2013 2012 Feb - Genotoxicity in the pharmaceutical industry. University of Leiden, Leiden, POT course Mutagenicity and carcinogenicity, 10 February, 2012 Mar - Toxicogenomics in the pharmaceutical industry. University of Maastricht, Maastricht, POT course Toxicogenomics, 2 March, 2012 Jun - Toxicogenomics within the pharmaceutical industry. General usage and the selection and validation of genotoxic biomarkers. RIVM, Bilthoven, 28 June 2012. 2011 Jan - Toxicogenomics in the pharmaceutical industry. Radboud University Nijmegen, Nijmegen, POT course Organ toxicity, Toxicogenomic Course, 12 January, 2011 Jan - High Content Screening on micronuclei and phospholipidosis. 6th meeting on: Human predictive toxicity and ADME/TOX studies, 27- 28 Januari, 2011, Mondial Research Group, Brussel, Belgium. Mar - Toxicogenomics in the pharmaceutical industry. University of Maastricht, Maastricht, POT Course Toxicogenomics, 4 March, 2011 Jul - Toxicogenomics in the pharmaceutical industry. 6th annual conference of SMi on ADMET 6-7 July, 2011, Cornthorpe Tara, London, United Kingdom. 2010 Jan - High throughput screening analysis for genotoxicity and clastogenicity. 5th meeting on: Human predictive toxicity and ADME/TOX studies, 28-29 Januari, 2010, Mondial Research Group, Brussel, Belgium. Feb - Toxicogenomics in the pharmaceutical industry. Ecotec, 22th and 23th Februari, Malaga, Spain. Feb - Toxicogenomics in the pharmaceutical industry. University of Maastricht, Maastricht, Toxicogenomic Course, 26 February, 2010 Mar - Analysing in vitro toxicity by high throughput and high content screening. High content analysis. 4th Annual Meeting. 17th and 18th March, Berlin, Germany. Jun - ADME/TOX meeting, 7th and 8th June, Cologne, Germany. Jul - Segragation of genotoxic compounds. 5th annual conference of SMi on ADMET 7-8 July, 2010, Crown’s Plaza St. James, London, United Kingdom. Aug - SBS Course on High Content screening applications. High content screening for micronuclei testing and phospholipidosis. 31th August, Coventry, UK Sep - Toxicogenomics in the pharmaceutical industry. EEMS, 16th and 17th September, Oslo, Norway. Oct - High throughput screening within the pharmaceutical industry. Luciferase based genotoxicity assays. 14th and 15th October, BDS, Science Park, Amsterdam 2009 Jan - High throughput screening analysis for genotoxicity and clastogenicity. 4rd meeting on: Human predictive toxicity and ADME/TOX studies, 22-23 Januari, 2009, Mondial Research Group, Brussel, Belgium. Feb - Toxicogenomics in the pharmaceutical industry. University of Maastricht, Maastricht, Toxicogenomic Course, 28 February, 2009. Feb - Identification of Non-Genotoxic Carcinogens with the Arylhydrocarbon receptor (AhR) and the peroxisomal proliferator activating Receptor α (PPARα). Molecular Conceptor, Case Studies in ADME/TOX predictions. D2.1.1 http://www.drugdesign.com Jul - High throughput screening for genotoxicity and clastogenicity. 4th annual conference of SMi on ADMET 1-2 July, 2009, Crown’s Plaza St. James, London, United Kingdom. Sep - High throughput screening for genotoxicity and clastogenicity. Society for Medicines Research (SMR), 24th September, National Heart and Lung Institute, Kensington, London.
  2. 2. 2008 Jan - High throughput screening for in vitro toxicity testing: A gradual acceptance of new test methods. 3rd meeting on: Human predictive toxicity and ADME/TOX studies, 24-25 Januari, 2008, Mondial Research Group, Brussel, Belgium. Feb - Toxicogenomics in the pharmaceutical industry. University of Maastricht, Maastricht, Toxicogenomic Course, 29 February, 2008. Apr - High throughput screening for in vitro toxicity testing. Workshop in vitro toxicity. 2-4 April, 2008, Milano, Italy. Jul - High throughput screening for in vitro toxicity testing: A gradual acceptance of new test methods. 3rd annual conference of SMi on ADMET 2-3 July, 2008 The Hatton, London, United Kingdom. Sep - High throughput screening for in vitro toxicity testing: Fast genotoxic screening. Ehrlich II, 3-5 Oct, 2008, Gymnasium, Nürnberg, Germany. Oct - High throughput screening for in vitro toxicity testing: gradual acceptance. Miptec meeting, satellite seminar of Promega, 14-16 Oct, 2008, Congress centre, Basel, Switserland. Nov - High throughput screening analysis for genotoxicity and clastogenicity. Cell-Based assays, SMi group, 19-20 Nov 2008, Crown Plaza – St. James, London, United Kingdom. 2007 Jan - High throughput screening for in vitro toxicity testing. Predictive ADME/TOX meeting Mondial Research Group, Brussel, Belgium. Feb - Promega Seminar, High throughput screening for in vitro toxicity testing. Utrecht, TheNetherlands. Mar - Validation methods of cellular assays for screening. Hogeschool Breda, Breda, The Netherlands. Jun - Exploration of toxicity outcome measures. High content analysis, Vienna, Austria. Sep - High throughput screening for in vitro toxicity testing. SCTT congress, Salzau, Germany. Nov - High throughput screening for in vitro toxicity testing. Rikilt, Wageningen, The Netherlands. 2006 Mar - Toxicogenomics course. University of Maastricht, Maastricht, The Netherlands. Sep - High throughput screening for in vitro toxicity testing. Morris, Leuven, Belgium. 2005 Apr - Predictive ADME/Tox congress, High throughput screening for in vitro toxicity testing. London, United Kingdom. Sep - Promega Seminar, High throughput screening for in vitro toxicity testing. Utrecht, The Netherlands. Nov - High throughput screening for in vitro toxicity testing. Genotoxocity symposium, Oss, The Netherlands. 2004 Apr - Predictive ADME/Tox congress, High throughput screening for in vitro toxicity testing. Berlin, Germany. May - Devgen, High throughput screening for in vitro toxicicity testing. Ghent, Belgium. Nov - Bioanale, Toxicogenomics and pharmaceutical industry. Maastricht, The Netherlands. 2003 Nov - Biodetection systems, High throughput screening for in vitro toxicity testing. Amsterdam, The Netherlands. 1999 Feb - Schoonen W.G.E.J., Vermeulen, G.J., Deckers, G.H., Verbost, P.M. and Kloosterboer, H.J. (1999): Antiprogestins: mechanism of action and in vitro and in vivo selection. Doorwerth (lecture), Febr . The Netherlands. NVE, Dutch society for endocrinology. Antiprogestins: mechanism of action and in vitro / in vivo selection. May - Packard users meeting, Development of in vitro bioassays for high throughput screening of steroid receptors. London, United Kingdom. Sep - Schoonen W.G.E.J., Vermeulen, G.J., Deckers, G.H., Verbost, P.M. and Kloosterboer, H.J. (1999): Antiprogestins: mechanism of action and in vitro and in vivo selection. Sixth International Congress on Hormones and Cancer. Abstract Page 6. Jerusalem, Sept 5-9, Israel. 1998 Apr - Schoonen W.G.E.J. Development of an in vitro assay for progestagenic activity based on stably transfected CHO cells. Son discussie groep Farmacochemie, Lunteren, The Netherlands. May -Packard users meeting, Development of in vitro bioassays for high throughput screening of steroid receptors. London, United Kingdom.

×